TrialJournal of the American Academy of Dermatology2023

Secukinumab improves mild-to-moderate psoriasis: A randomized, placebo-controlled exploratory clinical trial.

Jaehwan Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.